Introduction:
Rheumatoid arthritis (RA) was independently associated with cardiovascular events in several studies, most of which were conducted in the US.
Objectives:
To estimate the risk of cardiovascular events in a cohort of RA patients recruited at a hospital in France, to identify cardiovascular risk factors, and to measure the severity of cardiovascular events.
Methods:
Two hundred and thirty-nine patients admitted between January 1, 1998, and March 31, 1999, for RA meeting American College of Rheumatology criteria, with a negative history for cardiovascular events, were sent a questionnaire in 2004 to evaluate the occurrence of myocardial infarction, stroke, or cardiovascular death.
Results:
During the mean follow-up of 5.4+/-1.8 years, there were 10 cases of myocardial infarction (0.8%/year), 3 cases of stroke (0.2%/year), and 9 cardiovascular deaths (0.7%/year). Of the 10 patients who experienced myocardial infarction, 5 had clinical symptoms of heart failure and 4 died from cardiovascular causes. Independent risk factors for cardiovascular events were older age (relative risk [RR], 2.5/10 years; 95% confidence interval [95%CI], 1.4-4.2), male gender (RR, 5.1; 95%CI, 1.8-14.6), treated hypertension (RR, 4.3; 95%CI, 1.4-13.2), and treated hypercholesterolemia (RR, 6.0; 95%CI, 1.8-20.7).
Conclusion:
Our data suggest a higher risk of cardiovascular events in patients with RA compared to the general population in France (0.1-0.5%/year for myocardial infarction and 0.07%/year for stroke in the age group covered by our cohort). Cardiovascular events in the patients with RA seemed unusually severe. Patients with RA should be carefully screened for conventional cardiovascular risk factors.
Citing Articles
The interaction of perfluoroalkyl acids and a family history of diabetes on arthritis: analyses of 2011-2018 NHANES.
Yang S, Li X, Jiang Z
BMC Public Health. 2024; 24(1):448.
PMID: 38347551
PMC: 10863084.
DOI: 10.1186/s12889-024-17879-2.
Prevalence of Hypertension and Its Associated Risk Factors Among Patients with Rheumatoid Arthritis in the Kingdom of Saudi Arabia.
Al-Ahmari A
Int J Gen Med. 2022; 15:6507-6517.
PMID: 35966507
PMC: 9374201.
DOI: 10.2147/IJGM.S370956.
Is hypertension associated with arthritis? The United States national health and nutrition examination survey 1999-2018.
Liang X, Chou O, Cheung C, Cheung B
Ann Med. 2022; 54(1):1767-1775.
PMID: 35786117
PMC: 9258429.
DOI: 10.1080/07853890.2022.2089911.
Established and Emerging Mechanisms in the Pathogenesis of Arrhythmogenic Cardiomyopathy: A Multifaceted Disease.
Gao S, Puthenvedu D, Lombardi R, Chen S
Int J Mol Sci. 2020; 21(17).
PMID: 32878278
PMC: 7503882.
DOI: 10.3390/ijms21176320.
Effect of methotrexate use on the development of type 2 diabetes in rheumatoid arthritis patients: A systematic review and meta-analysis.
Baghdadi L
PLoS One. 2020; 15(7):e0235637.
PMID: 32628710
PMC: 7337336.
DOI: 10.1371/journal.pone.0235637.
Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment.
Jagpal A, Navarro-Millan I
BMC Rheumatol. 2019; 2:10.
PMID: 30886961
PMC: 6390616.
DOI: 10.1186/s41927-018-0014-y.
Association between urinary sodium and potassium excretion and blood pressure and inflammation in patients with rheumatoid arthritis.
Carranza-Leon D, Octaria R, Ormseth M, Oeser A, Solus J, Zhang Y
Clin Rheumatol. 2017; 37(4):895-900.
PMID: 29243056
PMC: 5912908.
DOI: 10.1007/s10067-017-3935-8.
Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases.
Bartoloni E, Alunno A, Gerli R
Nat Rev Cardiol. 2017; 15(1):33-44.
PMID: 28836617
DOI: 10.1038/nrcardio.2017.118.
The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis.
Baghdadi L, Woodman R, Shanahan E, Mangoni A
PLoS One. 2015; 10(2):e0117952.
PMID: 25689371
PMC: 4331556.
DOI: 10.1371/journal.pone.0117952.
Cardiovascular case fatality in rheumatoid arthritis is decreasing; first prospective analysis of a current low disease activity rheumatoid arthritis cohort and review of the literature.
Meek I, Vonkeman H, van de Laar M
BMC Musculoskelet Disord. 2014; 15:142.
PMID: 24779371
PMC: 4046075.
DOI: 10.1186/1471-2474-15-142.
A comparative analysis of serological parameters and oxidative stress in osteoarthritis and rheumatoid arthritis.
Mishra R, Singh A, Chandra V, Negi M, Tripathy B, Prakash J
Rheumatol Int. 2011; 32(8):2377-82.
PMID: 21644045
DOI: 10.1007/s00296-011-1964-1.
The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus.
Full L, Ruisanchez C, Monaco C
Arthritis Res Ther. 2009; 11(2):217.
PMID: 19435478
PMC: 2688172.
DOI: 10.1186/ar2631.
Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in....
Visser K, Katchamart W, Loza E, Martinez-Lopez J, Salliot C, Trudeau J
Ann Rheum Dis. 2008; 68(7):1086-93.
PMID: 19033291
PMC: 2689523.
DOI: 10.1136/ard.2008.094474.
C-reactive protein is linked to lower cognitive performance in overweight and obese women.
Sweat V, Starr V, Bruehl H, Arentoft A, Tirsi A, Javier E
Inflammation. 2008; 31(3):198-207.
PMID: 18347963
PMC: 3116730.
DOI: 10.1007/s10753-008-9065-3.